Lifevantage Market Cap 2010-2023 | LFVN
Lifevantage market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Lifevantage market cap as of April 26, 2024 is $0.08B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.080B | $0.213B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $70.953B | 18.99 |
| Becton Dickinson (BDX) | United States | $66.586B | 19.34 |
| West Pharmaceutical Services (WST) | United States | $26.953B | 48.06 |
| Cardinal Health (CAH) | United States | $25.250B | 15.18 |
| Align Technology (ALGN) | United States | $23.366B | 45.13 |
| Cooper (COO) | United States | $17.874B | 27.05 |
| Labcorp (LH) | United States | $16.686B | 14.39 |
| Henry Schein (HSIC) | United States | $9.356B | 16.18 |
| DENTSPLY SIRONA (XRAY) | United States | $6.293B | 16.58 |
| Merit Medical Systems (MMSI) | United States | $4.261B | 24.38 |
| Patterson (PDCO) | United States | $2.311B | 11.07 |
| STAAR Surgical (STAA) | United States | $2.304B | 72.14 |
| CONMED (CNMD) | United States | $1.906B | 17.29 |
| Atrion (ATRI) | United States | $0.702B | 36.17 |
| Pro-Dex (PDEX) | United States | $0.065B | 24.61 |
| Biolase (BIOL) | United States | $0.005B | 0.00 |